Sensors of ionizing radiation effects on the immunological microenvironment of cancer

International Journal of Radiation Biology

Volumn 83, Issue 11-12, 2007, Pages 819-825

  Demaria, Sandra ^a   Formenti, Silvia C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytolytic T cells; Immunotherapy; Ionizing radiation; Microenvironment

Indexed keywords

TUMOR VACCINE;

BIOSENSOR; CANCER RADIOTHERAPY; CELL DEATH; CELL SURVIVAL; GENE MUTATION; IMMUNITY; IMMUNOTHERAPY; IONIZING RADIATION; MICROENVIRONMENT; MOLECULAR INTERACTION; NECROSIS; NONHUMAN; NUTRIENT SUPPLY; PRIORITY JOURNAL; RADIATION RESPONSE; REVIEW; TUMOR;

ANIMALS; HUMANS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 36849031260     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000701481816     Document Type: Review

References (55)

1. Barcellos-Hoff MH, Park C, Wright EG. 2005. Radiation and the microenvironment - tumorigenesis and therapy. Nature Reviews Cancer 5:867-875.
2. Benlagha K, Bendelac A. 2000. CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: Lymphocytes of innate immunity. Seminars in Immunology 12:537-542.
3. Bissell MJ, Kenny PA, Radisky DC. 2005. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes. Cold Spring Harbor Symposia on Quantitative Biology 70:343-356.
4. Burnet M. 1957. Cancer: A biological approach. British Medical Journal 1:841-847.
5. Carlos TM. 2001. Leukocyte recruitment at sites of tumor: Dissonant orchestration. Journal of Leukocyte Biology 70:171-184.
6. Cella M, Sallusto F, Lanzavecchia A. 1997. Origin, maturation and antigen presenting function of dendritic cells. Current Opinion in Immunology 9:10-16.
7. Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW. 2003. Irradiation of tumor cells upregulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. Journal of Immunology 170:6338-6347.
8. Chakravarty PK, Alfieri A, Thomas EK, Beri V, Tanaka KE, Vikram B, Guha C. 1999. Flt3-Ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Research 59:6028-6032.
9. Chen Q, Wang WC, Evans SS. 2003. Tumor microvasculature as a barrier to antitumor immunity. Cancer Immunology Immunotherapy 52:670-679.
10. Chiang CS, Syljuasen RG, Hong JH, Wallis A, Dougherty GJ, McBride WH. 1997. Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. Cancer Research 57:3899-3903.
11. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine 10:942-949.
12. Dallal RM, Lotze MT. 2000. The dendritic cell and human cancer vaccines. Current Opinion in Immunology 12:583-588.
13. Demaria S, Kawashima N, Yang AM, Devitt M-L, Babb JS, Allison JP, Formenti SC. 2005a. Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clinical Cancer Research 11:728-734.
14. Demaria S, Ng B, Devitt M-L, Babb JS, Kawashima N, Liebes L, Formenti SC. 2004. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. International Journal of Radiation Oncology, Biology, Physics 58:862-870.
15. Demaria S, Santori FR, Ng B, Liebes L, Formenti SC, Vukmanovic S. 2005b. Select forms of tumor cell apoptosis induce dendritic cell maturation. Journal of Leukocyte Biology 77:361-368.
16. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. 2002. Cancer immunoediting: From immunosurveillance to tumor escape. Nature Immunology 3:991-998.
17. Egen JG, Kuhns MS, Allison JP. 2002. CTLA-4: New insights into its biological function and use in tumor immunotherapy. Nature Immunology 3:611-618.
18. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Medicine 2:1096-1103.
19. Gajewski TF, Meng Y, Blank C, Brown I, Kacha A, Kline J, Harlin H. 2006. Immune resistance orchestrated by the tumor microenvironment. Immunological Reviews 213:131-145.
20. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964.
21. Ganss R, Ryschich E, Klar E, Arnold B, Hammerling GJ. 2002. Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. Cancer Research 62:1462-1470.
22. Garnett CT, Palena C, Chakarborty M, Tsang KY, Schlom J, Hodge JW. 2004. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Research 64:7985-7994.
23. Gaugler MH, Squiban C, van der Meeren A, Bertho JM, Vandamme M, Mouthon MA. 1997. Late and persistent upregulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. International Journal of Radiation Biology 72:201-209.
24. Hallahan D, Kuchibhotla J, Wyble C. 1996. Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. Cancer Research 56:5150-5155.
25. Hallahan DE, Virudachalam S. 1999. Accumulation of P-selectin in the lumen of irradiated blood vessels. Radiation Research 152:6-13.
26. Hareyama M, Imai K, Kubo K, Takahashi H, Koshiba H, Hinoda Y, Shidou M, Oouchi A, Yachi A, Morita K. 1991. Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells. Cancer 67:2269-2274.
27. Jain RK. 1999. Transport of molecules, particles, and cells in solid tumors. Annual Review of Biomedical Engineering 1:241-263.
28. Kim KW, Kim SH, Shin JG, Kim GS, Son YO, Park SW, Kwon BH, Kim DW, Lee CH, Sol MY, Jeong MH, Chung BS, Kang CD. 2004. Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. International Journal of Cancer 109:685-690.
29. Kusmartsev S, Gabrilovich DI. 2002. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunology Immunotherapy 51:293-298.
30. Larsson M, Fonteneau JF, Bhardwaj N. 2001. Dendritic cells resurrect antigens from dead cells. Trends in Immunology 22:141-148.
31. Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. 2005. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Journal of Immunology 174:7516-7523.
32. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. 2000. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Advances in Immunology 74:181-273.
33. Mason KA, Ariga H, Neal R, Valdecanas D, Hunter N, Krieg AM, Whisnant JK, Milas L. 2005. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. Clinical Cancer Research 11:361-369.
34. Matzinger P. 1994. Tolerance, danger, and the extended family. Annual Review of Immunology12:991-1045.
35. McBride WH, Chiang C-S, Olson JL, Wang C-C, Hong J-H, Pajonk F, Dougherty GJ, Iwamoto KS, Pervan M, Liao Y-P. 2004. A sense of danger from radiation. Radiation Research 162:1-19.
36. Melief CJM. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Advances in Cancer Research 58:143-175.
37. Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert JK, Zagzag D, McBride WH, Formenti SC. 2006. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clinical Cancer Research 12:4730-4737.
38. Nikitina EY, Gabrilovich DI. 2001. Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer. International Journal of Cancer 94:825-833.
39. O'Neill DW, Adams S, Bhardwaj N. 2004. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104:2235-2246.
40. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Metivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G. 2007. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine 13:54-61.
41. Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ. 2006. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. Journal of Experimental Medicine 203:1259-1271.
42. Rock KL, Goldberg AL. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annual Review of Immunology 17:739-779.
43. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. Journal of Experimental Medicine 191:423-433.
44. Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V. 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunology Immunotherapy 53:64-72.
45. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107-1111.
46. Shimizu J, Yamazaki S, Sakaguchi S. 1999. Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity. Journal of Immunology 163:5211-5218.
47. Skoberne M, Beignon AS, Bhardwaj N. 2004. Danger signals: A time and space continuum. Trends in Molecular Medicine 10:251-257.
48. Smyth MJ, Godfrey DI, Trapani JA. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nature Immunology 2:293-299.
49. Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE. 2003. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Cancer Research 63:8466-8475.
50. Thomas L. 1959. Discussion. In: Lawrence HS, editor. Cellular and humoral aspects of the hypersensitive states. New York: Hoeber-Harper. pp 529-532.
51. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich DI, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine 10:48-54.
52. Wersall PJ, Blomgren H, Pisa P, Lax I, Kalkner KM, Svedman C. 2006. Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma. Acta Oncologica 45:493-497.
53. Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX. 2005. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. Journal of Experimental Medicine 201:779-791.
54. Zagzag D, Salnikow K, Chiriboga L, Yee HT, Lan L, Ali MA, Garcia R, Demaria S, Newcomb EW. 2005. Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain. Laboratory Investigation 85:328-341.
55. Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX, Weichselbaum RR, Rowley DA, Kranz DM, Schreiber H. 2007. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. Journal of Experimental Medicine 204:49-55.